Genpact Ltd. Files Q2 2024 10-Q Report
Ticker: G · Form: 10-Q · Filed: Aug 9, 2024 · CIK: 1398659
| Field | Detail |
|---|---|
| Company | Genpact LTD (G) |
| Form Type | 10-Q |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Genpact's Q2 2024 10-Q is in. Check financials.
AI Summary
Genpact Ltd. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024, detailing financial performance and operational updates. Specific financial figures and operational highlights for the quarter are presented within the report.
Why It Matters
This filing provides investors and analysts with the latest financial results and operational details for Genpact Ltd., crucial for understanding the company's current performance and future outlook.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Players & Entities
- Genpact LTD (company) — Filer
- 20240630 (date) — Period of Report
- 20240809 (date) — Filing Date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240630, indicating the filing covers the period ending June 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20240809.
What is Genpact Ltd.'s Standard Industrial Classification code?
Genpact Ltd.'s SIC code is 8742, categorized under SERVICES-MANAGEMENT CONSULTING SERVICES.
Where is Genpact Ltd. incorporated?
Genpact Ltd. is incorporated in D0.
What is the fiscal year end for Genpact Ltd.?
Genpact Ltd.'s fiscal year ends on 1231.
Filing Stats: 4,606 words · 18 min read · ~15 pages · Grade level 19 · Accepted 2024-08-09 12:46:31
Key Financial Figures
- $0.01 — ch registered Common shares, par value $0.01 per share G New York Stock Exchange I
Filing Documents
- g-20240630.htm (10-Q) — 1984KB
- g-20240630x10qex221.htm (EX-22.1) — 7KB
- g-20200930x10qex311101.htm (EX-31.1) — 9KB
- g-20200930x10qex312101.htm (EX-31.2) — 9KB
- g-20200930x10qex321101.htm (EX-32.1) — 4KB
- g-20200930x10qex322101.htm (EX-32.2) — 4KB
- 0001398659-24-000088.txt ( ) — 11690KB
- g-20240630.xsd (EX-101.SCH) — 92KB
- g-20240630_cal.xml (EX-101.CAL) — 107KB
- g-20240630_def.xml (EX-101.DEF) — 377KB
- g-20240630_lab.xml (EX-101.LAB) — 976KB
- g-20240630_pre.xml (EX-101.PRE) — 702KB
- g-20240630_htm.xml (XML) — 1980KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
Unaudited Consolidated Financial Statements
Item 1. Unaudited Consolidated Financial Statements GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Balance Sheets (Unaudited) (In thousands, except per share data and share count) Notes As of December 31, 2023 As of June 30, 2024 Assets Current assets Cash and cash equivalents $ 583,670 $ 914,171 Accounts receivable, net of allowance for credit losses of $ 18,278 and $ 16,833 as of December 31, 2023 and June 30, 2024, respectively 3 1,116,273 1,159,787 Prepaid expenses and other current assets 6 191,566 192,123 Total current assets $ 1,891,509 $ 2,266,081 Property, plant and equipment, net 8 189,803 199,533 Operating lease right-of-use assets 186,167 194,624 Deferred tax assets 22 298,921 276,981 Intangible assets, net 9 53,028 39,841 Goodwill 9 1,683,782 1,677,866 Contract cost assets 19 202,543 203,402 Other assets, net of allowance for credit losses of $ 4,096 and $ 5,512 as of December 31, 2023 and June 30, 2024, respectively 299,960 319,937 Total assets $ 4,805,713 $ 5,178,265 Liabilities and equity Current liabilities Short-term borrowings 10 $ 10,000 $ — Current portion of long-term debt 11 432,242 425,918 Accounts payable 27,739 28,430 Income taxes payable 22 38,458 43,779 Accrued expenses and other current liabilities 12 759,180 653,676 Operating leases liability 50,313 45,879 Total current liabilities $ 1,317,932 $ 1,197,682 Long-term debt, less current portion 11 824,720 1,207,610 Operating leases liability 168,015 175,693 Deferred tax liabilities 22 11,706 10,118 Other liabilities 13 234,948 249,403 Total liabilities $ 2,557,321 $ 2,840,506 Shareholders' equity Preferred shares, $ 0.01 par value, 250,000,000 authorized, none issued — — Common shares, $ 0.01 par value, 500,000,000 authorized, 179,494,132 and 178,177,581 issued and outstanding as of December 31, 2023 and June 30, 2024, respectively 1,789 1,776 Additional paid-in capital 1,883,944 1,900,015 Retained earnings 1,085,209 1,176,459 Accumulated